Publication | Closed Access
Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma
18
Citations
26
References
2021
Year
Lymphoid NeoplasiaSurgical OncologyOncologyRefractory Hodgkin LymphomaCancer ManagementPathologyImmune Checkpoint InhibitorNivolumab DiscontinuationCancer TreatmentImmunotherapyMedicineRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1